Abstract
The aim of this study was to determine the clinical, laboratory, and endoscopic findings that might be related to poor prognoses, such as rebleeding or death, in patients admitted to the emergency room with upper gastrointestinal (UGI) bleeding. A prospective evaluation was conducted in 99 patients with UGI bleeding who were admitted to the emergency room of Hacettepe University Medical School between May and December 2001. Twenty-four patients were considered to have a poor prognosis. In multivariate analyses, presence of diabetes mellitus or of visible vessel at endoscopy, treatment with proton pump inhibitors, and decrease in mean blood pressure were found to be independent predictors for poor prognoses in this population. Several factors, such as comorbidities, type of treatment, or clinical and endoscopic findings, were found to be related to rebleeding or death in patients admitted to the emergency room with UGI bleeding necessitating intensive care.
Similar content being viewed by others
References
Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastrointestinal haemorrhage in four French geographical areas.Eur J Gastroenterol Hepatol. 2000;12: 175–181.
Rockall TA, Logan RFA, Devlin HB, et al. Incidence and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom.BMJ. 1995;311:22–26.
Sanders DS, Carter MJ, Goodchap RJ, Cross SS, Gleeson DC, Lobo AJ. Prospective validation of the Rockall Risk Scoring for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers.Am J Gastroenterol. 2002;97:630–635.
Das A, Richard CK, Wong MB. Prediction of outcome of acute GI hemorrhage: a review of risk scores and predictive models.Gastrointest Endosc. 2004;60:85–93.
Gralnek MI, Dulai GS. Incremental value of upper endoscopy for triage of patients with acute non-variceal upper-GI hemorrhage.Gastrointest Endosc. 2004;60:9–14.
Rockall TA, Logan RF, Devlin HB, Northfield TC, the Steering Committee of the National Audit of Acute UGIB. Influencing the practice and outcome in acute UGIB.Gut. 1997;41:606–611.
Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding.Gut. 1999;44:331–335.
Van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute GI bleeding between 1993/1994 and 2000.Am J Gastroenterol. 2003;98:1494–1499.
Cooper G, Chak A, Way L. Effectiveness of early endoscopy in upper GI hemorrhage.Gastrointest Endosc. 1999;49:145–152.
Conrad SA. Acute upper gastrointestinal bleeding in critically ill patients: causes and treatment modalities.Crit Care Med. 2002;30:365–368.
Barkun A, Sabbah S, Enns R, et al. The Canadian registry on nonvariceal upper gastrointestinal bleeding and endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real life setting.Am J Gastroenterol. 2004;24:1238–1246.
Rockall TA, Logan RF, Devlin HB, Northfield TC, the Steering Committee of the National Audit of Acute UGIB and members of the National Audit of Acute UGIH. Risk assessment after acute upper gastrointestinal hemorrhage.Gut. 1996;38:316–321.
Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage.BMJ. 1995;311:222–226.
Freeman ML, Cass OW, Peine CJ, Onstad GR. The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding.Gastrointest Endosc. 1993;3:359–366.
Consensus Conference. Therapeutic endoscopy and bleeding ulcers.JAMA. 1989;262:1369–1372.
Gostout CJ, Wang KK, Ahlquist DA, et al. Acute gastrointestinal bleeding. Experience of a specialized management team.J Clin Gastroenterol. 1992;14:260–267.
Bleau BL, Gostout CJ, Sherman KE, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.Gastrointest Endosc. 2002;56:1–6.
Chalasani N, Patel K, Clark WS. The prevalence and significance of leukocytosis in upper gastrointestinal bleeding.Am J Med Sci. 1998;315:233–236.
Jaramillo JL, Galvez C, Carmona C, Montero JL, Mino G. Prediction of further hemorrhage in bleeding peptic ulcer.Am J Gastroenterol. 1994;89:2135–2138.
Clason AE, MacLeod DA, Elton RA. Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal haemorrhage.Br J Surg. 1986;73:985–987.
Morgan AF, McAdam WAF, Walmsley CE, et al. Clinical finding, early endoscopy and multivariate analysis in patients bleeding from the upper gastrointestinal tract.BMJ. 1977;2:237–240.
Bornan PC, Theodorou NA, Shuttleworth RD, et al. Importance of hypovolemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation.BMJ. 1985;291:245–247.
Chalasani N, Patel K, Clark WS. The prevalence and significance of leukocytosis in upper gastrointestinal bleeding.Am J Med Sci. 1998;315:233–236.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coskun, F., Topeli, A. & Sivri, B. Patients admitted to the emergency room with upper gastrointestinal bleeding: Factors influencing recurrence or death. Adv Therapy 22, 453–461 (2005). https://doi.org/10.1007/BF02849865
Issue Date:
DOI: https://doi.org/10.1007/BF02849865